Tucci V, Haran M A, Isenberg H D
Pathology Department, Long Island Jewish Medical Center, Albert Einstein College of Medicine, New Hyde Park, NY 11040, USA.
Am J Infect Control. 1997 Oct;25(5):371-6. doi: 10.1016/s0196-6553(97)90080-8.
The incidence of vancomycin-resistant enterococci (VRE) has reached endemic proportions in many medical centers. To initiate an effective infection control program, an understanding of the epidemiologic attributes of the genus in medical facilities is imperative.
We studied 138 consecutive cases of VRE from April through December 1995. We created a database to analyze the risk factors for patients in both an adult hospital and a children's hospital and screened all specimens, submitted for routine microbiologic analysis, for VRE.
One hundred twenty-three cases (89%) occurred in the adult acute care hospital, and 15 (11%) occurred in the children's hospital. Eighty patients (58%) were colonized with VRE, and 58 (42%) had an infection with VRE. Eighty-three percent of all the cases of VRE were nosocomially acquired. The majority of cases occurred in the medical service. Urine was the most important clinical specimen infected or colonized. Prior use of an antibiotic, other than vancomycin, was the most important risk factor for all nosocomial cases, followed by prior vancomycin use for surgical patients and residence in a unit with other patients infected with VRE for the medical service. Direct admission from another hospital was the most important risk factor for community-acquired cases. Special microbiologic screening of cultures yielded 48% of all VRE identified. Enterococcus faecium was the predominant resistant isolate recovered.
The control of VRE in the hospital setting is difficult for several reasons. Almost half of all patients carrying VRE would not have been identified without special microbiologic screening efforts, as would patients, admitted from the community, who are already colonized with VRE. Controlling antibiotic use both in the hospital and the community is basic for controlling these organisms. Continuous education of all staff about VRE and other nosocomially significant organisms is the key to controlling the spread of these bacteria.
耐万古霉素肠球菌(VRE)的发病率在许多医疗中心已达到地方流行程度。为启动有效的感染控制计划,了解该菌属在医疗机构中的流行病学特征至关重要。
我们研究了1995年4月至12月期间连续的138例VRE病例。我们创建了一个数据库,以分析一家成人医院和一家儿童医院中患者的危险因素,并对所有提交进行常规微生物分析的标本进行VRE筛查。
123例(89%)发生在成人急性护理医院,15例(11%)发生在儿童医院。80例患者(58%)被VRE定植,58例(42%)发生VRE感染。所有VRE病例的83%是医院获得性的。大多数病例发生在医疗科室。尿液是最重要的被感染或定植的临床标本。除万古霉素外,先前使用过抗生素是所有医院感染病例最重要的危险因素,其次是外科患者先前使用万古霉素以及在医疗科室与其他感染VRE的患者同住。从另一家医院直接入院是社区获得性病例最重要的危险因素。特殊的微生物培养筛查发现了所有鉴定出的VRE中的48%。屎肠球菌是回收的主要耐药菌株。
由于多种原因,在医院环境中控制VRE很困难。如果没有特殊的微生物筛查措施,几乎一半携带VRE的患者将无法被识别,从社区入院且已被VRE定植的患者也是如此。控制医院和社区的抗生素使用是控制这些微生物的基础。对所有工作人员持续开展关于VRE和其他医院感染重要微生物的教育是控制这些细菌传播的关键。